References
- De, Larco J E, Todaro G J. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA. 1978; 75: 4001–5. [PUBMED]
- Anzano M A, Roberts A B, Meyers C A, et al, Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 1982; 42: 4776–8. [PUBMED]
- Anzano M A, Roberts A B, Smith J M, et al, Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type α and type β transforming growth factors. Proc Natl Acad Sci USA. 1983; 80: 6264–8. [PUBMED]
- Derynck R, Jarrett J A, Chen E Y, et al, Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 1985; 316: 701–5. [PUBMED]
- Derynck R, Lindquist P B, Lee A, et al, A new type of transforming growth factor-β, TGF-β 3. Embo J. 1988; 7: 3737–43. [PUBMED]
- de, Martin R, Haendler B, Hofer-Warbinek R, et al, Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. Embo J. 1987; 6: 3673–7. [PUBMED]
- Kingsley D M.. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994; 8: 133–46. [PUBMED], [INFOTRIEVE]
- Massague J, Cheifetz S, Laiho M, et al, Transforming growth factor-β. Cancer Surv. 1992; 12: 81–103. [PUBMED]
- Koli K, Saharinen J, Hyytiainen M, et al, Latency, activation, and binding proteins of TGF-β. Microsc Res Tech. 2001; 52: 354–62. [CROSSREF], [PUBMED]
- Moses H L.. TGF-β regulation of epithelial cell proliferation. Mol Reprod Dev. 1992; 32: 179–84. [PUBMED]
- Massague J.. TGF-β signal transduction. Annu Rev Biochem. 1998; 67: 753–91. [CROSSREF], [PUBMED]
- Massague J.. How cells read TGF-β signals. Nat Rev Mol Cell Biol. 2000; 1: 169–78. [CROSSREF], [PUBMED]
- Massague J.. Transforming growth factor-β modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-α. J Cell Biol. 1985; 100: 1508–14. [CROSSREF], [PUBMED]
- Tucker R F, Shipley G D, Moses H L, et al, Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science. 1984; 226: 705–7. [PUBMED]
- Takehara K, LeRoy E C, Grotendorst G R.. TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell. 1987; 49: 415–22. [CROSSREF], [PUBMED]
- Frolik C A, Dart L L, Meyers C A, et al, Purification and initial characterization of a type β transforming growth factor from human placenta. Proc Natl Acad Sci USA. 1983; 80: 3676–80. [PUBMED]
- Assoian R K, Komoriya A, Meyers C A, et al, Transforming growth factor-β in human platelets: Identification of a major storage site, purification, and characterization. J Biol Chem. 1983; 258: 7155–60. [PUBMED]
- Hanks S K, Armour R, Baldwin J H, et al, Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci USA. 1988; 85: 79–82. [PUBMED]
- ten, Dijke P, Hansen P, Iwata K K, et al, Identification of another member of the transforming growth factor type β gene family. Proc Natl Acad Sci USA. 1988; 85: 4715–9. [PUBMED]
- Jakowlew S B, Dillard P J, Kondaiah P, et al, Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-β messenger ribonucleic acid from chick embryo chondrocytes. Mol Endocrinol. 1988; 2: 747–55. [PUBMED]
- Kondaiah P, Sands M J, Smith J M, et al, Identification of a novel transforming growth factor-β (TGF-β 5) mRNA in Xenopus laevis. J Biol Chem. 1990; 265: 1089–93. [PUBMED]
- Pan H, Halper J.. Cloning, expression, and characterization of chicken transforming growth factor β 4. Biochem Biophys Res Commun. 2003; 303: 24–30. [CROSSREF], [PUBMED]
- Annes J P, Munger J S, Rifkin D B.. Making sense of latent TGF-β activation. J Cell Sci. 2003; 116: 217–24. [CROSSREF], [PUBMED]
- Attisano L, Wrana J L.. Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev. 1996; 7: 327–39. [CROSSREF], [PUBMED]
- Massague J, Weis-Garcia F.. Serine/threonine kinase receptors: Mediators of transforming growth factor β family signals. Cancer Surv. 1996; 27: 41–64. [PUBMED]
- Cheifetz S, Hernandez H, Laiho M, et al, Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem. 1990; 265: 20533–8. [PUBMED]
- Pelton R W, Saxena B, Jones M, et al, Immunohistochemical localization of TGF β 1, TGF β 2, and TGF β 3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol. 1991; 115: 1091–105. [CROSSREF], [PUBMED]
- Shull M M, Ormsby I, Kier A B, et al, Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature. 1992; 359: 693–9. [CROSSREF], [PUBMED]
- Sanford L P, Ormsby I, Gittenberger-de Groot A C, et al, TGF-β2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development. 1997; 124: 2659–70. [PUBMED]
- Kaartinen V, Voncken J W, Shuler C, et al, Abnormal lung development and cleft palate in mice lacking TGF-β 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet. 1995; 11: 415–21. [PUBMED]
- Proetzel G, Pawlowski S A, Wiles M V, et al, Transforming growth factor-β 3 is required for secondary palate fusion. Nat Genet. 1995; 11: 409–14. [PUBMED]
- Siegel P M, Massague J.. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer. 2003; 3: 807–21. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Teicher B A.. Malignant cells, directors of the malignant process: Role of transforming growth factor-β. Cancer Metastasis Rev. 2001; 20: 133–43. [CROSSREF], [PUBMED]
- Cui W, Fowlis D J, Bryson S, et al, TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 1996; 86: 531–42. [CROSSREF], [PUBMED]
- Pasche B.. Role of transforming growth factor β in cancer. J Cell Physiol. 2001; 186: 153–68. [CROSSREF], [PUBMED]
- Moses H L, Serra R.. Regulation of differentiation by TGF-β. Curr Opin Genet Dev. 1996; 6: 581–6. [CROSSREF], [PUBMED]
- Shah N M, Groves A K, Anderson D J.. Alternative neural crest cell fates are instructively promoted by TGF-β superfamily members. Cell. 1996; 85: 331–43. [CROSSREF], [PUBMED]
- Keski-Oja J, Raghow R, Sawdey M, et al, Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem. 1988; 263: 3111–5. [PUBMED]
- Roberts A B, Sporn M B, Assoian R K, et al, Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 1986; 83: 4167–71. [PUBMED]
- Keski-Oja J, Lohi J, Koli K, Laiho M.. Growth factors in the regulation of plasminogen-plasmin system in tumor cells. Semin Thromb Hemostas. 1991; 17: 231–9
- Laiho M, Saksela O, Keski-Oja J.. Transforming growth factor β alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res. 1986; 164: 399–407. [PUBMED]
- Laiho M, Saksela O, Andreasen P A, et al, Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol. 1986; 103: 2403–10. [CROSSREF], [PUBMED]
- Heino J, Ignotz R A, Hemler M E, et al, Regulation of cell adhesion receptors by transforming growth factor-β: Concomitant regulation of integrins that share a common β 1 subunit. J Biol Chem. 1989; 264: 380–8. [PUBMED]
- Riikonen T, Koivisto L, Vihinen P, et al, Transforming growth factor-β regulates collagen gel contraction by increasing α 2 β 1 integrin expression in osteogenic cells. J Biol Chem. 1995; 270: 376–82. [PUBMED]
- Nejjari M, Hafdi Z, Dumortier J, et al, α6β1 integrin expression in hepatocarcinoma cells: Regulation and role in cell adhesion and migration. Int J Cancer. 1999; 83: 518–25. [CROSSREF], [PUBMED]
- Thibault G, Lacombe M J, Schnapp L M, et al, Upregulation of α(8)β(1)-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-β1. Am J Physiol Cell Physiol. 2001; 281: C1457–67. [PUBMED]
- Giannelli G, Fransvea E, Marinosci F, et al, Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin. Am J Pathol. 2002; 161: 183–93. [PUBMED]
- Heino J, Massague J.. Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J Biol Chem. 1989; 264: 21806–11. [PUBMED]
- Kumar N M, Sigurdson S L, Sheppard D, et al, Differential modulation of integrin receptors and extracellular matrix laminin by transforming growth factor-β 1 in rat alveolar epithelial cells. Exp Cell Res. 1995; 221: 385–94. [CROSSREF], [PUBMED]
- Lim S P, Leung E, Krissansen G W.. The β7 integrin gene (Itgb-7) promoter is responsive to TGF-β1: Defining control regions. Immunogenetics. 1998; 48: 184–95. [CROSSREF], [PUBMED]
- Gorelik L, Flavell R A.. Transforming growth factor-β in T-cell biology. Nat Rev Immunol. 2002; 2: 46–53. [CROSSREF], [PUBMED]
- Letterio J J, Roberts A B.. Regulation of immune responses by TGF-β. Annu Rev Immunol. 1998; 16: 137–61. [CROSSREF], [PUBMED]
- Kehrl J H, Wakefield L M, Roberts A B, et al, Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986; 163: 1037–50. [CROSSREF], [PUBMED]
- Cerwenka A, Bevec D, Majdic O, et al, TGF-β 1 is a potent inducer of human effector T cells. J Immunol. 1994; 153: 4367–77. [PUBMED]
- Bogdan C, Nathan C.. Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann NY Acad Sci. 1993; 685: 713–39. [PUBMED]
- Cheifetz S, Weatherbee J A, Tsang M L, et al, The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell. 1987; 48: 409–15. [CROSSREF], [PUBMED]
- Ogawa Y, Schmidt D K, Dasch J R, et al, Purification and characterization of transforming growth factor-β 2.3 and -β 1.2 heterodimers from bovine bone. J Biol Chem. 1992; 267: 2325–8. [PUBMED]
- Gentry L E, Lioubin M N, Purchio A F, et al, Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor β to the mature polypeptide. Mol Cell Biol. 1988; 8: 4162–8. [PUBMED]
- Lawrence D A, Pircher R, Kryceve-Martinerie C, et al, Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol. 1984; 121: 184–8. [PUBMED]
- Dubois C M, Laprise M H, Blanchette F, et al, Processing of transforming growth factor β 1 precursor by human furin convertase. J Biol Chem. 1995; 270: 10618–24. [PUBMED]
- Sha X, Brunner A M, Purchio A F, et al, Transforming growth factor β 1: Importance of glycosylation and acidic proteases for processing and secretion. Mol Endocrinol. 1989; 3: 1090–8. [PUBMED]
- Gentry L E, Nash B W.. The pro domain of pre-pro-transforming growth factor β 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry. 1990; 29: 6851–7. [PUBMED]
- McMahon G A, Dignam J D, Gentry L E.. Structural characterization of the latent complex between transforming growth factor β 1 and β 1-latency-associated peptide. Biochem J. 1996; 313: 343–51. [PUBMED]
- Miyazono K, Hellman U, Wernstedt C, et al, Latent high molecular weight complex of transforming growth factor β 1: Purification from human platelets and structural characterization. J Biol Chem. 1988; 263: 6407–15. [PUBMED]
- Wakefield L M, Smith D M, Flanders K C, et al, Latent transforming growth factor-β from human platelets: A high molecular weight complex containing precursor sequences. J Biol Chem. 1988; 263: 7646–54. [PUBMED]
- Kanzaki T, Olofsson A, Moren A, et al, TGF-β 1 binding protein: A component of the large latent complex of TGF-β 1 with multiple repeat sequences. Cell. 1990; 61: 1051–61. [CROSSREF], [PUBMED]
- Dallas S L, Park-Snyder S, Miyazono K, et al, Characterization and autoregulation of latent transforming growth factor β (TGF β) complexes in osteoblast-like cell lines: Production of a latent complex lacking the latent TGF β-binding protein. J Biol Chem. 1994; 269: 6815–21. [PUBMED]
- Olofsson A, Miyazono K, Kanzaki T, et al, Transforming growth factor-β 1, -β 2, and -β 3 secreted by a human glioblastoma cell line: Identification of small and different forms of large latent complexes. J Biol Chem. 1992; 267: 19482–8. [PUBMED]
- Taipale J, Lohi J, Saarinen J, et al, Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem. 1995; 270: 4689–96. [PUBMED]
- Taipale J, Miyazono K, Heldin C H, et al, Latent transforming growth factor-β 1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol. 1994; 124: 171–81. [CROSSREF], [PUBMED]
- Miyazono K, Olofsson A, Colosetti P, et al, A role of the latent TGF-β 1-binding protein in the assembly and secretion of TGF-β 1. EMBO J. 1991; 10: 1091–101. [PUBMED]
- Saharinen J, Taipale J, Keski-Oja J.. Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1. EMBO J. 1996; 15: 245–53. [PUBMED]
- ten, Dijke P, Miyazono K, Heldin C H.. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol. 1996; 8: 139–45. [PUBMED]
- Piek E, Heldin C H, Ten, Dijke P.. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J. 1999; 13: 2105–24. [PUBMED]
- Sankar S, Mahooti-Brooks N, Centrella M, et al, Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor β 2. J Biol Chem. 1995; 270: 13567–72. [PUBMED]
- Massague J, Andres J, Attisano L, et al, TGF-β receptors. Mol Reprod Dev. 1992; 32: 99–104. [PUBMED]
- Blobe G C, Liu X, Fang S J, et al, A novel mechanism for regulating transforming growth factor β (TGF-β) signaling. Functional modulation of type III TGF-β receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem. 2001; 276: 39608–17. [CROSSREF], [PUBMED]
- Eickelberg O, Centrella M, Reiss M, et al, Betaglycan inhibits TGF-β signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function. J Biol Chem. 2002; 277: 823–9. [PUBMED]
- Lopez-Casillas F, Payne H M, Andres J L, et al, Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: Mapping of ligand binding and GAG attachment sites. J Cell Biol. 1994; 124: 557–68. [CROSSREF], [PUBMED]
- Letamendia A, Lastres P, Botella L M, et al, Role of endoglin in cellular responses to transforming growth factor-β. A comparative study with betaglycan. J Biol Chem. 1998; 273: 33011–9. [CROSSREF], [PUBMED]
- Attisano L, Wrana J L.. Smads as transcriptional co-modulators. Curr Opin Cell Biol. 2000; 12: 235–43. [CROSSREF], [PUBMED]
- Wakefield L M, Winokur T S, Hollands R S, et al, Recombinant latent transforming growth factor β 1 has a longer plasma half-life in rats than active transforming growth factor β 1, and a different tissue distribution. J Clin Invest. 1990; 86: 1976–84. [PUBMED]
- LaMarre J, Wollenberg G K, Gauldie J, et al, α 2-macroglobulin and serum preferentially counteract the mitoinhibitory effect of transforming growth factor-β 2 in rat hepatocytes. Lab Invest. 1990; 62: 545–51. [PUBMED]
- LaMarre J, Hayes M A, Wollenberg G K, et al, An α 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-β 1 in mice. J Clin Invest. 1991; 87: 39–44. [PUBMED]
- Stach R M, Rowley D A.. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor β and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med. 1993; 178: 841–52. [CROSSREF], [PUBMED]
- Bouchard C, Galinha A, Tartour E, et al, A transforming growth factor β-like immunosuppressive factor in immunoglobulin G-binding factor. J Exp Med. 1995; 182: 1717–26. [CROSSREF], [PUBMED]
- Caver T E, O'Sullivan F X, Gold L I, et al, Intracellular demonstration of active TGFβ1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFβ1 suppresses neutrophil function and host defense against Staphylococcus aureus infection. J Clin Invest. 1996; 98: 2496–506. [PUBMED]
- Yamaguchi Y, Mann D M, Ruoslahti E.. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature. 1990; 346: 281–4. [CROSSREF], [PUBMED]
- Riquelme C, Larrain J, Schonherr E, et al, Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor β and accelerates skeletal muscle differentiation. J Biol Chem. 2001; 276: 3589–96. [CROSSREF], [PUBMED]
- Zhao J, Sime P J, Bringas P, Jr, et al, Adenovirus-mediated decorin gene transfer prevents TGF-β-induced inhibition of lung morphogenesis. Am J Physiol. 1999; 277: L412–22. [PUBMED]
- Takeuchi Y, Kodama Y, Matsumoto T.. Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J Biol Chem. 1994; 269: 32634–8. [PUBMED]
- Fava R A, McClure D B.. Fibronectin-associated transforming growth factor. J Cell Physiol. 1987; 131: 184–9. [PUBMED]
- Paralkar V M, Vukicevic S, Reddi A H.. Transforming growth factor β type 1 binds to collagen IV of basement membrane matrix: Implications for development. Dev Biol. 1991; 143: 303–8. [PUBMED]
- Brown P D, Wakefield L M, Levinson A D, et al, Physicochemical activation of recombinant latent transforming growth factor-β's 1, 2, and 3. Growth Factors. 1990; 3: 35–43. [PUBMED]
- Lyons R M, Keski-Oja J, Moses H L.. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol. 1988; 106: 1659–65. [CROSSREF], [PUBMED]
- Salo J, Lehenkari P, Mulari M, et al, Removal of osteoclast bone resorption products by transcytosis. Science. 1997; 276: 270–3. [CROSSREF], [PUBMED]
- Oursler M J.. Osteoclast synthesis and secretion and activation of latent transforming growth factor β. J Bone Miner Res. 1994; 9: 443–52. [PUBMED]
- Schultz-Cherry S, Hinshaw V S.. Influenza virus neuraminidase activates latent transforming growth factor β. J Virol. 1996; 70: 8624–9. [PUBMED]
- Miyazono K, Heldin C H.. Role for carbohydrate structures in TGF-β 1 latency. Nature. 1989; 338: 158–60. [CROSSREF], [PUBMED]
- Yang Y, Dignam J D, Gentry L E.. Role of carbohydrate structures in the binding of β1-latency-associated peptide to ligands. Biochemistry. 1997; 36: 11923–32. [CROSSREF], [PUBMED]
- Bottinger E P, Factor V M, Tsang M L, et al, The recombinant proregion of transforming growth factor β1 (latency- associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc Natl Acad Sci USA. 1996; 93: 5877–82. [CROSSREF], [PUBMED]
- Barcellos-Hoff M H, Derynck R, Tsang M L, et al, Transforming growth factor-β activation in irradiated murine mammary gland. J Clin Invest. 1994; 93: 892–9. [PUBMED]
- Barcellos-Hoff M H, Dix T A.. Redox-mediated activation of latent transforming growth factor-β 1. Mol Endocrinol. 1996; 10: 1077–83. [CROSSREF], [PUBMED]
- Grainger D J, Wakefield L, Bethell H W, et al, Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin. Nat Med. 1995; 1: 932–7. [PUBMED]
- Antonelli-Orlidge A, Saunders K B, Smith S R, et al, An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA. 1989; 86: 4544–8. [PUBMED]
- Dennis P A, Rifkin D B.. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA. 1991; 88: 580–4. [PUBMED]
- Nunes I, Gleizes P E, Metz C N, et al, Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J Cell Biol. 1997; 136: 1151–63. [CROSSREF], [PUBMED]
- Flaumenhaft R, Abe M, Sato Y, et al, Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol. 1993; 120: 995–1002. [CROSSREF], [PUBMED]
- Flaumenhaft R, Kojima S, Abe M, et al, Activation of latent transforming growth factor β. Adv Pharmacol. 1993; 24: 51–76. [PUBMED], [INFOTRIEVE]
- Kojima S, Rifkin D B.. Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol. 1993; 155: 323–32. [PUBMED]
- Romer J, Bugge T H, Pyke C, et al, Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med. 1996; 2: 287–92. [PUBMED]
- Murphy-Ullrich J E, Poczatek M.. Activation of latent TGF-β by thrombospondin-1: Mechanisms and physiology. Cytokine Growth Factor Rev. 2000; 11: 59–69. [CROSSREF], [PUBMED]
- Bailly S, Brand C, Chambaz E M, et al, Analysis of small latent transforming growth factor-β complex formation and dissociation by surface plasmon resonance. Absence of direct interaction with thrombospondins. J Biol Chem. 1997; 272: 16329–34. [CROSSREF], [PUBMED]
- Grainger D J, Frow E K.. Thrombospondin 1 does not activate transforming growth factor β1 in a chemically defined system or in smooth-muscle-cell cultures. Biochem J. 2000; 350, (Pt 1). 291–8. [CROSSREF], [PUBMED]
- Ribeiro S M, Poczatek M, Schultz-Cherry S, et al, The activation sequence of thrombospondin-1 interacts with the latency- associated peptide to regulate activation of latent transforming growth factor-β. J Biol Chem. 1999; 274: 13586–93. [CROSSREF], [PUBMED]
- Schultz-Cherry S, Chen H, Mosher D F, et al, Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J Biol Chem. 1995; 270: 7304–10. [PUBMED]
- Agah A, Kyriakides T R, Lawler J, et al, The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol. 2002; 161: 831–9. [PUBMED]
- Crawford S E, Stellmach V, Murphy-Ullrich J E, et al, Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell. 1998; 93: 1159–70. [CROSSREF], [PUBMED]
- Daniel C, Wiede J, Krutzsch H C, et al, Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo. Kidney Int. 2004; 65: 459–68. [CROSSREF], [PUBMED]
- Yehualaeshet T, O'Connor R, Begleiter A, et al, A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am J Respir Cell Mol Biol. 2000; 23: 204–12. [PUBMED]
- Ruoslahti E.. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996; 12: 697–715. [CROSSREF], [PUBMED]
- Munger J S, Harpel J G, Giancotti F G, et al, Interactions between growth factors and integrins: latent forms of transforming growth factor-β are ligands for the integrin αvβ1. Mol Biol Cell. 1998; 9: 2627–38. [PUBMED]
- Munger J S, Huang X, Kawakatsu H, et al, The integrin α v β 6 binds and activates latent TGF β 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999; 96: 319–28. [CROSSREF], [PUBMED]
- Lu M, Munger J S, Steadele M, et al, Integrin α8β1 mediates adhesion to LAP-TGFβ1. J Cell Sci. 2002; 115: 4641–8. [CROSSREF], [PUBMED]
- Mu D, Cambier S, Fjellbirkeland L, et al, The integrin α(v)β8 mediates epithelial homeostasis through MT1- MMP-dependent activation of TGF-β1. J Cell Biol. 2002; 157: 493–507. [CROSSREF], [PUBMED]
- Annes J P, Rifkin D B, Munger J S.. The integrin αVβ6 binds and activates latent TGF-β3. FEBS Lett. 2002; 511: 65–8. [CROSSREF], [PUBMED]
- Yu Q, Stamenkovic I.. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 2000; 14: 163–76. [PUBMED]
- Perrin B J, Huttenlocher A.. Calpain. Int J Biochem Cell Biol. 2002; 34: 722–5. [CROSSREF], [PUBMED]
- Abe M, Oda N, Sato Y.. Cell-associated activation of latent transforming growth factor-β by calpain. J Cell Physiol. 1998; 174: 186–93. [CROSSREF], [PUBMED]
- Dangelo M, Sarment D P, Billings P C, et al, Activation of transforming growth factor β in chondrocytes undergoing endochondral ossification. J Bone Miner Res. 2001; 16: 2339–47. [PUBMED]
- D'Angelo M, Billings P C, Pacifici M, et al, Authentic matrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-β. J Biol Chem. 2001; 276: 11347–53. [CROSSREF], [PUBMED]
- Maeda S, Dean D D, Gay I, et al, Activation of latent transforming growth factor β1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles. J Bone Miner Res. 2001; 16: 1281–90. [PUBMED]
- Maeda S, Dean D D, Gomez R, et al, The first stage of transforming growth factor β1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif Tissue Int. 2002; 70: 54–65. [CROSSREF], [PUBMED]
- Tsuji T, Okada F, Yamaguchi K, et al, Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci USA. 1990; 87: 8835–9. [PUBMED]
- Moren A, Olofsson A, Stenman G, et al, Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J Biol Chem. 1994; 269: 32469–78. [PUBMED]
- Gibson M A, Hatzinikolas G, Davis E C, et al, Bovine latent transforming growth factor β 1-binding protein 2: Molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol. 1995; 15: 6932–42. [PUBMED]
- Yin W, Smiley E, Germiller J, et al, Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J Biol Chem. 1995; 270: 10147–60. [PUBMED]
- Giltay R, Kostka G, Timpl R.. Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-β binding proteins. FEBS Lett. 1997; 411: 164–8. [CROSSREF], [PUBMED]
- Saharinen J, Taipale J, Monni O, et al, Identification and characterization of a new latent transforming growth factor-β-binding protein, LTBP-4. J Biol Chem. 1998; 273: 18459–69. [CROSSREF], [PUBMED]
- Penttinen C, Saharinen J, Weikkolainen K, et al, Secretion of human latent TGF-β-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-β. J Cell Sci. 2002; 115: 3457–68. [PUBMED]
- Davis C G.. The many faces of epidermal growth factor repeats. New Biol. 1990; 2: 410–9. [PUBMED]
- Saharinen J, Keski-Oja J.. Specific sequence motif of 8-Cys repeats of TGF-β binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β. Mol Biol Cell. 2000; 11: 2691–704. [PUBMED]
- Shipley J M, Mecham R P, Maus E, et al, Developmental expression of latent transforming growth factor β binding protein 2 and its requirement early in mouse development. Mol Cell Biol. 2000; 20: 4879–87. [CROSSREF], [PUBMED]
- Maslen C L, Corson G M, Maddox B K, et al, Partial sequence of a candidate gene for the Marfan syndrome. Nature. 1991; 352: 334–7. [CROSSREF], [PUBMED]
- Pereira L, D'Alessio M, Ramirez F, et al, Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet. 1993; 2: 961–8. [PUBMED]
- Sakai L Y, Keene D R, Engvall E.. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986; 103: 2499–509. [CROSSREF], [PUBMED]
- Zhang H, Apfelroth S D, Hu W, et al, Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol. 1994; 124: 855–63. [CROSSREF], [PUBMED]
- Corson G M, Charbonneau N L, Keene D R, et al, Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. Genomics. 2004; 83: 461–72. [CROSSREF], [PUBMED]
- Reinhardt D P, Chalberg S C, Sakai L Y.. The structure and function of fibrillin. Ciba Found Symp. 1995; 192: 128–43, discussion. 143–7. [PUBMED]
- Rosenbloom J, Abrams W R, Mecham R.. Extracellular matrix 4: The elastic fiber. FASEB J. 1993; 7: 1208–18. [PUBMED]
- Sakai L Y, Keene D R.. Fibrillin: Monomers and microfibrils. Methods Enzymol. 1994; 245: 29–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lee B, Godfrey M, Vitale E, et al, Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991; 352: 330–4. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ramirez F.. Fibrillin mutations in Marfan syndrome and related phenotypes. Curr Opin Genet Dev. 1996; 6: 309–15. [CROSSREF], [PUBMED]
- Ramirez F, Pereira L.. The fibrillins. Int J Biochem Cell Biol. 1999; 31: 255–9. [CROSSREF], [PUBMED]
- Handford P, Downing A K, Rao Z, et al, The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1. J Biol Chem. 1995; 270: 6751–6. [PUBMED]
- Reinhardt D P, Ono R N, Sakai L Y.. Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem. 1997; 272: 1231–6. [PUBMED]
- Gleizes P E, Beavis R C, Mazzieri R, et al, Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor-β1. J Biol Chem. 1996; 271: 29891–6. [PUBMED]
- Lack J, O'Leary J M, Knott V, et al, Solution structure of the third TB domain from LTBP1 provides insight into assembly of the large latent complex that sequesters latent TGF-β. J Mol Biol. 2003; 334: 281–91. [CROSSREF], [PUBMED]
- Trask T M, Ritty T M, Broekelmann T, et al, N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: A possible first step in microfibril assembly. Biochem J. 1999; 340(Pt 3): 693–701
- D'Arrigo C, Burl S, Withers A P, et al, TGF-β1 binding protein-like modules of fibrillin-1 and -2 mediate integrin-dependent cell adhesion. Connect Tissue Res. 1998; 37: 29–51. [PUBMED]
- Pfaff M, Reinhardt D P, Sakai L Y, et al, Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett. 1996; 384: 247–50. [CROSSREF], [PUBMED]
- Sakamoto H, Broekelmann T, Cheresh D A, et al, Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J Biol Chem. 1996; 271: 4916–22. [PUBMED]
- Vehviläinen P, Hyytiäinen M, Keski-Oja J.. Latent transforming growth factor-β-binding protein 2 is an adhesion protein for melanoma cells. J Biol Chem. 2003; 278: 24705–13
- Hyytiäinen M, Keski-Oja J.. Latent TGF-β binding protein LTBP-2 decreases fibroblast adhesion to fibronectin. J Cell Biol. 2003; 163: 1363–74
- Olofsson A, Ichijo H, Moren A, et al, Efficient association of an amino-terminally extended form of human latent transforming growth factor-β binding protein with the extracellular matrix. J Biol Chem. 1995; 270: 31294–7. [PUBMED]
- Corson G M, Chalberg S C, Dietz H C, et al, Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics. 1993; 17: 476–84. [CROSSREF], [PUBMED]
- Weiskirchen R, Moser M, Gunther K, et al, The murine latent transforming growth factor-β binding protein (Ltbp-1) is alternatively spliced, and maps to a region syntenic to human chromosome 2p21–22. Gene. 2003; 308: 43–52. [CROSSREF], [PUBMED]
- Noguera I, Obata H, Gualandris A, et al, Molecular cloning of the mouse Ltbp-1 gene reveals tissue specific expression of alternatively spliced forms. Gene. 2003; 308: 31–41. [CROSSREF], [PUBMED]
- Koski C, Saharinen J, Keski-Oja J.. Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-β binding protein-1 (LTBP-1) in a cell type-specific manner. J Biol Chem. 1999; 274: 32619–30. [CROSSREF], [PUBMED]
- Michel K, Roth S, Trautwein C, et al, Analysis of the expression pattern of the latent transforming growth factor β binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region. Hepatology. 1998; 27: 1592–9. [PUBMED]
- Gong W, Roth S, Michel K, et al, Isoforms and splice variant of transforming growth factor β-binding protein in rat hepatic stellate cells. Gastroenterology. 1998; 114: 352–63. [PUBMED]
- Öklü R, Metcalfe J C, Hesketh T R, et al, Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-β binding protein-1. FEBS Lett. 1998; 425: 281–5
- Downing A K, Knott V, Werner J M, et al, Solution structure of a pair of calcium-binding epidermal growth factor-like domains: Implications for the Marfan syndrome and other genetic disorders. Cell. 1996; 85: 597–605. [CROSSREF], [PUBMED]
- Krohn K.. TGF-β1-dependent differential expression of a rat homolog for latent TGF-β binding protein in astrocytes and C6 glioma cells. Glia. 1999; 25: 332–42. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Yin W, Smiley E, Bonadio J.. Alternative splicing of LTBP-3. Biochem Biophys Res Commun. 1998; 245: 454–8. [CROSSREF], [PUBMED]
- Unsöld C, Hyytiainen M, Bruckner-Tuderman L, et al, Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci. 2001; 114: 187–97
- Koli K, Saharinen J, Karkkainen M, et al, Novel non-TGF-β-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-β deposition. J Cell Sci. 2001; 114: 2869–78. [PUBMED]
- Saharinen J, Hyytiainen M, Taipale J, et al, Latent transforming growth factor-β binding proteins (LTBPs)—structural extracellular matrix proteins for targeting TGF-β action. Cytokine Growth Factor Rev. 1999; 10: 99–117. [CROSSREF], [PUBMED]
- Altmann C R, Chang C, Munoz-Sanjuan I, et al, The latent-TGFβ-binding-protein-1 (LTBP-1) is expressed in the organizer and regulates nodal and activin signaling. Dev Biol. 2002; 248: 118–27. [CROSSREF], [PUBMED]
- Quarto N.. Molecular cloning and expression study of Xenopus latent TGF-β binding protein-1 (LTBP-1). Gene. 2002; 290: 53–61. [CROSSREF], [PUBMED]
- Weikkolainen K, Keski-Oja J, Koli K.. Expression of latent TGF-β binding protein LTBP-1 is hormonally regulated in normal and transformed human lung fibroblasts. Growth Factors. 2003; 21: 51–60. [CROSSREF], [PUBMED]
- Koli K, Keski-Oja J.. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor β 1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res. 1995; 55: 1540–6. [PUBMED]
- Westhoff J H, Sawitza I, Keski-Oja J, et al, PDGF-BB induces expression of LTBP-1 but not TGF-β1 in a rat cirrhotic fat storing cell line. Growth Factors. 2003; 21: 121–30. [CROSSREF], [PUBMED]
- Santiago-Josefat B, Mulero-Navarro S, Dallas S L, et al, Overexpression of latent transforming growth factor-β binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts. J Cell Sci. 2004; 117: 849–59. [CROSSREF], [PUBMED]
- Zhang H, Hu W, Ramirez F.. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol. 1995; 129: 1165–76. [CROSSREF], [PUBMED]
- Gualandris A, Annes J P, Arese M, et al, The latent transforming growth factor-β-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium. Mol Biol Cell. 2000; 11: 4295–308. [PUBMED]
- Taipale J, Saharinen J, Hedman K, et al, Latent transforming growth factor-β 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem. 1996; 44: 875–89. [PUBMED]
- Sterner-Kock A, Thorey I S, Koli K, et al, Disruption of the gene encoding the latent transforming growth factor-β binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev. 2002; 16: 2264–73. [CROSSREF], [PUBMED]
- Dallas S L, Keene D R, Bruder S P, et al, Role of the latent transforming growth factor β binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo. J Bone Miner Res. 2000; 15: 68–81. [PUBMED]
- Sinha S, Heagerty A M, Shuttleworth C A, et al, Expression of latent TGF-β binding proteins and association with TGF-β 1 and fibrillin-1 following arterial injury. Cardiovasc Res. 2002; 53: 971–83. [CROSSREF], [PUBMED]
- Isogai Z, Ono R N, Ushiro S, et al, Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem. 2003; 278: 2750–7. [CROSSREF], [PUBMED]
- Hyytiäinen M, Taipale J, Heldin C H, et al, Recombinant latent transforming growth factor β-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem. 1998; 273: 20669–76
- Chen Y, Dabovic B, Annes J P, et al, Latent TGF-β binding protein-3 (LTBP-3) requires binding to TGF-β for secretion. FEBS Lett. 2002; 517: 277–80. [CROSSREF], [PUBMED]
- Taipale J, Keski-Oja J.. Growth factors in the extracellular matrix. FASEB J. 1997; 11: 51–9. [PUBMED]
- Robinson P N, Godfrey M.. The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet. 2000; 37: 9–25. [CROSSREF], [PUBMED]
- Kielty C M, Raghunath M, Siracusa L D, et al, The tight skin mouse: Demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils. J Cell Biol. 1998; 140: 1159–66. [CROSSREF], [PUBMED]
- Kainulainen K, Karttunen L, Puhakka L, et al, Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet. 1994; 6: 64–9. [PUBMED]
- Milewicz D M, Grossfield J, Cao S N, et al, A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest. 1995; 95: 2373–8. [PUBMED]
- Stahl-Hallengren C, Ukkonen T, Kainulainen K, et al, An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome. J Clin Invest. 1994; 94: 709–13. [PUBMED]
- Sood S, Eldadah Z A, Krause W L, et al, Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet. 1996; 12: 209–11. [PUBMED]
- Wirtz M K, Samples J R, Kramer P L, et al, Weill-Marchesani syndrome—possible linkage of the autosomal dominant form to 15q21.1. Am J Med Genet. 1996; 65: 68–75. [CROSSREF], [PUBMED]
- Tan F K, Stivers D N, Foster M W, et al, Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population. Arthritis Rheum. 1998; 41: 1729–37. [CROSSREF], [PUBMED]
- Neptune E R, Frischmeyer P A, Arking D E, et al, Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003; 33: 407–11. [CROSSREF], [PUBMED]
- Kaartinen V, Warburton D.. Fibrillin controls TGF-β activation. Nat Genet. 2003; 33: 331–2. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Waltenberger J, Wanders A, Fellstrom B, et al, Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol. 1993; 151: 1147–57. [PUBMED]
- Maeda J, Ueki N, Ohkawa T, et al, Local production and localization of transforming growth factor-β in tuberculous pleurisy. Clin Exp Immunol. 1993; 92: 32–8. [PUBMED]
- Karonen T, Jeskanen L, Keski-Oja J.. Transforming growth factor β 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: Accumulation in actinic damage and absence in anetoderma. Br J Dermatol. 1997; 137: 51–8. [CROSSREF], [PUBMED]
- Border W A, Noble N A.. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994; 331: 1286–92. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schlotzer-Schrehardt U, Zenkel M, Kuchle M, et al, Role of transforming growth factor-β1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001; 73: 765–80. [CROSSREF], [PUBMED]
- Mangasser-Stephan K, Gartung C, Lahme B, et al, Expression of isoforms and splice variants of the latent transforming growth factor β binding protein (LTBP) in cultured human liver myofibroblasts. Liver. 2001; 21: 105–13. [CROSSREF], [PUBMED]
- Kinnman N, Andersson U, Hultcrantz R.. In situ expression of transforming growth factor-β1–3, latent transforming growth factor-β binding protein and tumor necrosis factor-α in liver tissue from patients with chronic hepatitis C. Scand J Gastroenterol. 2000; 35: 1294–300. [PUBMED]
- Tamaki K, Okuda S, Miyazono K, et al, Matrix-associated latent TGF-β with latent TGF-β binding protein in the progressive process in adriamycin-induced nephropathy. Lab Invest. 1995; 73: 81–9. [PUBMED]
- van, Laethem J L, Deviere J, Resibois A, et al, Localization of transforming growth factor β 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology. 1995; 108: 1873–81. [PUBMED]
- Van, Laethem J L, Resibois A, Rickaert F, et al, Different expression of transforming growth factor β 1 in pancreatic ductal adenocarcinoma and cystic neoplasms. Pancreas. 1997; 15: 41–7. [PUBMED]
- Van, Laethem J L, Resibois A, Adler M, et al, Localization of transforming growth factor-β 1 precursor and latent TGF-β 1 binding protein in colorectal adenomas. Dig Dis Sci. 1996; 41: 1741–8. [PUBMED]
- Roth-Eichhorn S, Heitmann B, Flemming P, et al, Evidence for the decreased expression of the latent TGF-β binding protein and its splice form in human liver tumours. Scand J Gastroenterol. 2001; 36: 1204–10. [PUBMED]
- Henriksen R, Gobl A, Wilander E, et al, Expression and prognostic significance of TGF-β isotypes, latent TGF- β 1 binding protein, TGF-β type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab Invest. 1995; 73: 213–20. [PUBMED]
- Chaudhry A, Oberg K, Gobl A, et al, Expression of transforming growth factors β 1, β 2, β 3 in neuroendocrine tumors of the digestive system. Anticancer Res. 1994; 14: 2085–91. [PUBMED]
- Eklöv S, Funa K, Nordgren H, et al, Lack of the latent transforming growth factor β binding protein in malignant, but not benign prostatic tissue. Cancer Res. 1993; 53: 3193–7
- Mizoi T, Ohtani H, Matsuno S, et al, Immunohistochemical identification of transforming growth factor-β and its binding protein in human gastrointestinal carcinoma. Tohoku J Exp Med. 1992; 168: 271–3. [PUBMED]
- Dabovic B, Chen Y, Colarossi C, et al, Bone abnormalities in latent TGF-[β] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[β] bioavailability. J Cell Biol. 2002; 156: 227–32. [CROSSREF], [PUBMED]
- Dabovic B, Chen Y, Colarossi C, et al, Bone defects in latent TGF-β binding protein (Ltbp)-3 null mice; A role for Ltbp in TGF-β presentation. J Endocrinol. 2002; 175: 129–41. [PUBMED]
- Chen Y, Dabovic B, Colarossi C, et al, Growth retardation as well as spleen and thymus involution in latent TGF-β binding protein (Ltbp)-3 null mice. J Cell Physiol. 2003; 196: 319–25. [CROSSREF], [PUBMED]
- Filvaroff E, Erlebacher A, Ye J, et al, Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development. 1999; 126: 4267–79. [PUBMED]
- Janssens K, Gershoni-Baruch R, Guanabens N, et al, Mutations in the gene encoding the latency-associated peptide of TGF-β 1 cause Camurati-Engelmann disease. Nat Genet. 2000; 26: 273–5. [PUBMED]
- Erlebacher A, Derynck R.. Increased expression of TGF-β 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol. 1996; 132: 195–210. [CROSSREF], [PUBMED]
- Morris D G, Huang X, Kaminski N, et al, Loss of integrin α(v)β6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature. 2003; 422: 169–73. [CROSSREF], [PUBMED]